[1]
Jilani, H. et al. 2025. ASSESSING THE IMPACT OF LOW-DOSE ASPIRIN ON CARDIOVASCULAR DISEASE PREVENTION IN DIABETIC PATIENTS. Insights – Journal of Health and Rehabilitation. 3, 2 (Jan. 2025), 60–64. DOI:https://doi.org/10.71000/7828z391.